Richa Nand
Board Member
Sigyn Therapeutics, Inc. (SIGY)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Richa Nand
Richa Nand is recorded as Board Member at Sigyn Therapeutics, Inc. (SIGY). Sigyn Therapeutics, Inc. reported in an 8-K filed August 15, 2025 that Richa Nand resigned as Board of Directors, effective August 8, 2025. Sigyn Therapeutics, Inc. reported in an 8-K filed October 5, 2022 that Richa Nand was appointed Director, effective October 10, 2022.
“On August 8, 2025, Richa Nand and Michael Ryan notified Sigyn Therapeutics, Inc. (the "Company") of their decision to resign from the Company's Board of Directors, effective August 8, 2025.”
“The Board of Directors of Sigyn Therapeutics, Inc. ("the Company") appointed Jim Dorst, Richa Nand, and Christopher Wetzel to the Company's Board of Directors effective as of October 10, 2022.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-10-10–present
-
2022-10-10–2025-08-08
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Sigyn Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- James Joyce CEO, Chairman, Board Member
- Jerry DeCiccio CFO
- Craig Roberts CTO, Board Member
- Christopher Wetzel Board Member
- Jim Dorst Board Member
- Michael Ryan Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.